New NCAB Task Force On Clinical Trials Is Attempt To Bring NCI, Groups Together
In Brief: Ford Named Acting Deputy Director, DCPC; Foundation Leads Oncology Administrators
NSABP Investigator Recounts Loyalty To Fisher, “Betrayal”
NCAB Member Seeks Broder’s Resignation, Gets No support
Pittsburgh Broadens Misconduct Inquiry
Senate Appropriators Plan Hearing On NCI Ouster Of Fisher
DCE director Adamson To Retire August 31
DCPC Advisor O Trial Of Cervical Lesion Management With HPV
Trending Stories
- Jonathan Mahler on his front-page story in the NYT Magazine on Trump’s deliberate dismantling of America’s War on Cancer
- NCI releases names of members of ad hoc working group—filling the void left by BSA
- On Capitol Hill, NIH gets congressional support and RFK Jr. gets slammed
- The Directors: Ben Ho Park and Suresh Ramalingam discuss tough times, uncertainty, and resilience
“If you’re going to be an oncologist, we look at the glass 5% full, not 95% empty.” - Reflections of a cancer scientist
Maintaining the pace of novel technologies will lead to more efficient and less toxic medicines - NCI is “really, really sturdy” and won’t break, former directors Ned Sharpless and Kim Rathmell say at UNC Lineberger symposium